Dustin S. Sjuts - 30 Jun 2023 Form 4 Insider Report for Revance Therapeutics, Inc.

Role
President
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Jun 2023
Net transactions value
+$15,606
Form type
4
Filing time
05 Jul 2023, 21:11:24 UTC
Previous filing
13 Jun 2023
Next filing
15 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Award $15,606 +1,000 +0.68% $15.61 148,347 30 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired by Mr. Sjuts under the Issuer's 2014 Employee Stock Purchase Plan on June 30, 2023 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).